BioCentury | Feb 27, 2012
Company News

Broadvector, Vectura deal

...Vectura's Innovata Ltd. subsidiary granted Broadvector rights to IP covering a prodrug therapy for hip implant...
BioCentury | Oct 1, 2007
Finance

Repeat performance?

...$78.00 56% $3.7B in cash 11/9/06 Tanox Genentech $13.64 $20.00 47% $919M in cash 11/17/06 Innovata...
BioCentury | Jan 22, 2007
Company News

Innovata, Vectura deal

...Jan. 17, the last trading day before the deal closed (see BioCentury, Nov. 20, 2006). Innovata plc...
BioCentury | Dec 11, 2006
Finance

Top U.K. financings

...BioMedica 11/16/05 Placing and open £27.2 ($47.4) Ark Therapeutics 4/27/06 Placing and open £27.1 ($48.3) Innovata...
BioCentury | Dec 4, 2006
Analyst Picks & Changes

Analyst picks & changes

...a 116p target. Last month, the drug delivery company said it will acquire pulmonary play Innovata...
BioCentury | Nov 20, 2006
Company News

Innovata, Vectura deal

...Piper Jaffray advised VEC on the deal, which is expected to close by Jan. 16. Innovata plc...
BioCentury | Nov 18, 2006
Company News

Vectura to acquire Innovata

...Vectura (LSE:VEC) will acquire pulmonary company Innovata (LSE:IOV) for 26p per share, or L130.9 million ($250.1...
BioCentury | Oct 30, 2006
Analyst Picks & Changes

Analyst picks & changes

...dermatology play for $17.50 per share, or about $640M in cash (see "Connetics Chronicles," A21). Innovata...
BioCentury | Aug 7, 2006
Clinical News

Adept icodextrin regulatory update

...of Baxter International Inc. (BAX, Deerfield, Ill.). Adept has been marketed in Europe since 2000. Innovata plc...
BioCentury | Jun 5, 2006
Clinical News

Adept icodextrin regulatory update

...proposals for post-approval safety monitoring. IOV plans to submit this information as quickly as possible. Innovata plc...
Items per page:
1 - 10 of 92
BioCentury | Feb 27, 2012
Company News

Broadvector, Vectura deal

...Vectura's Innovata Ltd. subsidiary granted Broadvector rights to IP covering a prodrug therapy for hip implant...
BioCentury | Oct 1, 2007
Finance

Repeat performance?

...$78.00 56% $3.7B in cash 11/9/06 Tanox Genentech $13.64 $20.00 47% $919M in cash 11/17/06 Innovata...
BioCentury | Jan 22, 2007
Company News

Innovata, Vectura deal

...Jan. 17, the last trading day before the deal closed (see BioCentury, Nov. 20, 2006). Innovata plc...
BioCentury | Dec 11, 2006
Finance

Top U.K. financings

...BioMedica 11/16/05 Placing and open £27.2 ($47.4) Ark Therapeutics 4/27/06 Placing and open £27.1 ($48.3) Innovata...
BioCentury | Dec 4, 2006
Analyst Picks & Changes

Analyst picks & changes

...a 116p target. Last month, the drug delivery company said it will acquire pulmonary play Innovata...
BioCentury | Nov 20, 2006
Company News

Innovata, Vectura deal

...Piper Jaffray advised VEC on the deal, which is expected to close by Jan. 16. Innovata plc...
BioCentury | Nov 18, 2006
Company News

Vectura to acquire Innovata

...Vectura (LSE:VEC) will acquire pulmonary company Innovata (LSE:IOV) for 26p per share, or L130.9 million ($250.1...
BioCentury | Oct 30, 2006
Analyst Picks & Changes

Analyst picks & changes

...dermatology play for $17.50 per share, or about $640M in cash (see "Connetics Chronicles," A21). Innovata...
BioCentury | Aug 7, 2006
Clinical News

Adept icodextrin regulatory update

...of Baxter International Inc. (BAX, Deerfield, Ill.). Adept has been marketed in Europe since 2000. Innovata plc...
BioCentury | Jun 5, 2006
Clinical News

Adept icodextrin regulatory update

...proposals for post-approval safety monitoring. IOV plans to submit this information as quickly as possible. Innovata plc...
Items per page:
1 - 10 of 92